Evidence for autism spectrum disorder in Jacobsen syndrome: Identification of a candidate gene in distal 11q

Genetics in Medicine

Volumn 17, Issue 2, 2015, Pages 143-148

  Akshoomoff, Natacha ^a   Mattson, Sarah N ^b   Grossfeld, Paul D ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

11q terminal deletion; ARHGAP32; Autism spectrum disorder; Behavioral phenotype; Jacobsen syndrome

Indexed keywords

RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ARTICLE; AUTISM; BEHAVIOR ASSESSMENT; CHILD; CHROMOSOME 11Q; CLINICAL ARTICLE; COGNITION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENOTYPE; HUMAN; JACOBSEN SYNDROME; MALE; PHENOTYPE; PROSPECTIVE STUDY;

EID: 84964285296     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.86     Document Type: Article

References (41)

1. Jacobsen P, Hauge M, Henningsen K, Hobolth N, Mikkelsen M, Philip J. An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. Hum Hered 1973;23:568-585.
2. Mattina T, Perrotta CS, Grossfeld P. Jacobsen syndrome. Orphanet J Rare Dis 2009;4:9.
3. Grossfeld PD, Mattina T, Lai Z, et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A 2004;129A:51-61.
4. Lee WB, OHalloran HS, Grossfeld PD, Scher C, Jockin YM, Jones C. Ocular findings in Jacobsen syndrome. J AAPOS 2004;8:141-145.
5. Haghi M, Dewan A, Jones KL, Reitz R, Jones C, Grossfeld P. Endocrine abnormalities in patients with Jacobsen (11q-) syndrome. Am J Med Genet A 2004;129A:62-63.
6. Maas AP, Grossfeld PD, Didden R, et al. Sleep problems in individuals with 11q terminal deletion disorder (Jacobsen syndrome). Genet Couns 2008;19:225-235.
7. Coldren CD, Lai Z, Shragg P, et al. Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome). Neurogenetics 2009;10:89-95.
8. Bernaciak J, Szczauba K, Derwiska K, et al. Clinical and molecularcytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3). Am J Med Genet A 2008;146A:2449-2454.
9. Fisch GS, Grossfeld P, Falk R, Battaglia A, Youngblom J, Simensen R. Cognitivebehavioral features of Wolf-Hirschhorn syndrome and other subtelomeric microdeletions. Am J Med Genet C Semin Med Genet 2010;154C:417-426.
10. Guerin A, Stavropoulos DJ, Diab Y, et al. Interstitial deletion of 11q-implicating the KIRREL3 gene in the neurocognitive delay associated with Jacobsen syndrome. Am J Med Genet A 2012;158A:2551-2556.
11. Ye M, Hamzeh R, Geddis A, Varki N, Perryman MB, Grossfeld P. Deletion of JAMC, a candidate gene for heart defects in Jacobsen syndrome, results in a normal cardiac phenotype in mice. Am J Med Genet A 2009;149A:1438-1443.
12. Favier R, Jondeau K, Boutard P, et al. Paris-Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thromb Haemost 2003;90:893-897.
13. Rutter M, Bailey A, Lord C. Social Communication Questionnaire. Western Psychological Services: Los Angeles, CA, 2003.
14. Corsello C, Hus V, Pickles A, et al. Between a ROC and a hard place: decision making and making decisions about using the SCQ. J Child Psychol Psychiatry 2007;48:932-940.
15. Sparrow SS, Cicchetti DV, Balla DA. Vineland Adaptive Behavior Scales. II. Survey Forms Manual, 2nd edn. American Guidance Service: Circle Pines, MN, 2005.
16. Lord C, Risi S, DiLavore PS, Shulman C, Thurm A, Pickles A. Autism from 2 to 9 years of age. Arch Gen Psychiatry 2006;63:694-701.
17. Bayley N. Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), 3rd edn. Harcourt Brace & Co: San Antonio, TX, 2005.
18. Elliott CD. Differential Ability Scales. Psychological Corporation: San Antonio, TX, 1990.
19. Wechsler D. Wechsler Intelligence Scale for ChildrenFourth Edition. The Psychological Corporation: San Antonio, TX, 2003.
20. Wechsler D. Wechsler Adult Intelligence ScaleFourth Edition. Pearson Assessment: San Antonio, TX, 2008.
21. Lord C, Rutter M, DiLavore PC, Risi S. Autism Diagnostic Observation Schedule. Western Psychological Services: Los Angeles, CA, 2001.
22. Gotham K, Risi S, Pickles A, Lord C. The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity. J Autism Dev Disord 2007;37:613-627.
23. Gotham K, Risi S, Dawson G, et al. A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. J Am Acad Child Adolesc Psychiatry 2008;47:642-651.
24. Rutter M, Le Couteur A, Lord C. ADI-R. Autism Diagnostic Interview-Revised. WPS Edition. Western Psychological Services: Los Angeles, CA, 2003.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing: Arlington, VA, 2013.
26. Mahoney WJ, Szatmari P, MacLean JE, et al. Reliability and accuracy of differentiating pervasive developmental disorder subtypes. J Am Acad Child Adolesc Psychiatry 1998;37:278-285.
27. Risi S, Lord C, Gotham K, et al. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 2006;45:1094-1103.
28. Iascone M, Ciccone R, Galletti L, et al. Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clin Genet 2012;81:542-554.
29. Angkustsiri K, Goodlin-Jones B, Deprey L, Brahmbhatt K, Harris S, Simon TJ. Social impairments in chromosome 22q11.2 deletion syndrome (22q11.2DS): autism spectrum disorder or a different endophenotype? J Autism Dev Disord 2014;44:739-746.
30. Geschwind DH. Autism: many genes, common pathways? Cell 2008;135:391-395.
31. Zeidn-Chuli F, Rybarczyk-Filho JL, Salmina AB, de Oliveira BH, Noda M, Moreira JC. Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight. Neuromolecular Med 2013;15:364-383.
32. Levy D, Ronemus M, Yamrom B, et al. Rare de novo and transmitted copynumber variation in autistic spectrum disorders. Neuron 2011;70:886-897.
33. International Collaborative Study Group for Bartter-like Syndromes. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. Hum Mol Genet 1997;6:17-26.
34. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosteroneproducing adenomas and hereditary hypertension. Science 2011;331: 768-772.
35. Oda K, Arakawa H, Tanaka T, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000;102:849-862.
36. Nakamura T, Komiya M, Sone K, et al. Grit, a GTPase-activating protein for the Rho family, regulates neurite extension through association with the TrkA receptor and N-Shc and CrkL/Crk adapter molecules. Mol Cell Biol 2002;22:8721-8734.
37. Nasu-Nishimura Y, Hayashi T, Ohishi T, et al. Role of the Rho GTPase-activating protein RICS in neurite outgrowth. Genes Cells 2006;11:607-614.
38. Perry CA, Pravetoni M, Teske JA, et al. Predisposition to late-onset obesity in GIRK4 knockout mice. Proc Natl Acad Sci USA 2008;105:8148-8153.
39. Geschwind DH. Genetics of autism spectrum disorders. Trends Cogn Sci 2011;15:409-416.
40. Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010;42:203-209.
41. Girirajan S, Rosenfeld JA, Coe BP, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012;367: 1321-1331.